RGEN - Repligen misses top-line and bottom-line estimates; initiates FY24 outlook
2024-02-21 07:33:20 ET
- Repligen press release ( NASDAQ: RGEN ): Q4 Non-GAAP EPS of $0.33 misses by $0.01 .
- Revenue of $155.7M (-16.6% Y/Y) misses by $0.61M .
- Our cash, cash equivalents and short-term investments at December 31, 2023, were $751.3 million, compared to $623.8 million at December 31, 2022.
- FINANCIAL GUIDANCE FOR FISCAL YEAR 2024
| CURRENT GUIDANCE(at February 21, 2024) |
| FY 2024 |
| GAAP |
| Adjusted (non-GAAP) |
| Total Reported Revenue |
| $620M - $650M vs. $660.68Mconsensus |
| $620M - $650M |
| Year-over-Year Change |
| (3%) - 2% |
| (3%) - 2% |
| Base Revenue Growth |
| - |
| (1%) - 4% |
| Gross Margin |
| 49% - 50% |
| 49% - 50% |
| Income from Operations |
| $33M - $38M |
| $83M - $88M |
| Operating Margin |
| 5% - 6% |
| 13% - 14% |
| Other Income (Expense) |
| $2M - $3M |
| $18M - $19M |
| Adjusted EBITDA Margin |
| - |
| 18% - 19% |
| Tax Rate on Pre-Tax Income |
| 26% |
| 21% |
| Net Income |
| $26M - $30M |
| $80M - $84M |
| Earnings Per Share - Diluted |
| $0.46 - $0.53 |
| $1.42 - $1.49 vs. $1.77 consensus |